Investing.com - Equifax (NYSE: EFX) reported third quarter EPS of $1.76, $0.03 worse than the analyst estimate of $1.79. Revenue for the quarter came in at $1.32B versus the consensus estimate of $1.33B.
Guidance
Equifax sees Q4 2023 revenue of $1.31B-$1.33B versus the analyst consensus of $1.34B.
Equifax's stock price closed at $175.14. It is down -17.52% in the last 3 months and up 9.38% in the last 12 months.
Equifax saw 1 positive EPS revisions and 13 negative EPS revisions in the last 90 days. See Equifax's stock price’s past reactions to earnings here.
According to InvestingPro, Equifax's Financial Health score is "fair performance".
Check out Equifax's recent earnings performance, and Equifax's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar